Jun-Hang Luo
Impact in
- Cancer Research top 2%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Molecular Biology top 2%
- RNA modifications and cancer
- Circular RNAs in diseases
- Epigenetics and DNA Methylation
Papers in
-
- Renal cell carcinoma treatment 24
- Prostate Cancer Treatment and Research 4
-
- Cancer-related molecular mechanisms research 5
- Co-authors
- Dan Xie (16 shared papers)Jinhuan Wei (28 shared papers)Jiaxing Zhang (9 shared papers)Junjie Cen (22 shared papers)Haohua Yao (14 shared papers)Yong Fang (17 shared papers)Jun Kun Lu (22 shared papers)Lei Tan (9 shared papers)
- Journals
- Oncogene (5 papers)癌症：英文版 (4 papers)Cancer Letters (4 papers)Molecular Cancer (4 papers)Cancer Medicine (3 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Jun-Hang Luo
122 papers receiving 4.6k citations
Jun-Hang Luo's Hit Papers
Peers
Comparison fields: 5 of 77
- Cancer Research 510
- Molecular Biology 1.4k
- Pulmonary and Respiratory Medicine 534
- Drug Discovery 1
- Oncology 242
Countries citing papers authored by Jun-Hang Luo
This map shows the geographic impact of Jun-Hang Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jun-Hang Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jun-Hang Luo more than expected).
Fields of papers citing papers by Jun-Hang Luo
This network shows the impact of papers produced by Jun-Hang Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jun-Hang Luo. The network helps show where Jun-Hang Luo may publish in the future.
Co-authors
The 25 scholars most cited alongside Jun-Hang Luo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 126 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 5-methylcytosine promotes pathogenesis of bladder cancer through stabilizing mRNAs Hit paper breakdown → | 2019 | 635 |
| 2 | 2013 | 477 | |
| 3 | 2018 | 296 | |
| 4 | 2019 | 167 | |
| 5 | 2021 | 152 | |
| 6 | 2017 | 133 | |
| 7 | 2004 | 108 | |
| 8 | 2015 | 107 | |
| 9 | 2021 | 87 | |
| 10 | 2019 | 81 | |
| 11 | 2008 | 75 | |
| 12 | 2019 | 73 | |
| 13 | 2018 | 70 | |
| 14 | 2022 | 70 | |
| 15 | 2013 | 57 | |
| 16 | 2018 | 57 | |
| 17 | 2012 | 55 | |
| 18 | 2022 | 55 | |
| 19 | 2017 | 54 | |
| 20 | 2015 | 52 |
About Jun-Hang Luo
Jun-Hang Luo is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research, Oncology, Surgery and Molecular Biology, having authored 126 papers that have together received 4.6k indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (24 papers), Bladder and Urothelial Cancer Treatments (14 papers), Cancer Immunotherapy and Biomarkers (10 papers), Circular RNAs in diseases (10 papers), RNA modifications and cancer (5 papers), Cancer-related molecular mechanisms research (5 papers), Prostate Cancer Treatment and Research (4 papers) and Urologic and reproductive health conditions (4 papers). The work is most often cited by research in Cancer Research (510 citations), Molecular Biology (1.4k citations), Pulmonary and Respiratory Medicine (534 citations), Drug Discovery (1 citation) and Oncology (242 citations). Jun-Hang Luo has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Dan Xie, Jinhuan Wei, Jiaxing Zhang, Junjie Cen, Haohua Yao, Yong Fang, Jun Kun Lu, Lei Tan, Yong Huang and Bing Liao. Their work appears in journals such as Oncogene, 癌症：英文版, Cancer Letters, Molecular Cancer and Cancer Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.